OIP5 and gestational diabetes: The OIP5-AS1/miR-137-3p/EZH2 axis may function in HTR-8/SVneo cells under high-glucose conditions (58), suggesting that OIP5-AS1 could be a potential target for the prevention and treatment of GDM.